These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 1700819)
1. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids. Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro. Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355 [TBL] [Abstract][Full Text] [Related]
3. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of aminoglycoside-induced nephrotoxicity in rats by polyanionic peptides. Kishore BK; Lambricht P; Ibrahim S; Laurent G; Tulkens PM; Maldague P Contrib Nephrol; 1990; 83():191-201. PubMed ID: 1713134 [TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats. Kishore BK; Ibrahim S; Lambricht P; Laurent G; Maldague P; Tulkens PM J Pharmacol Exp Ther; 1992 Jul; 262(1):424-32. PubMed ID: 1378098 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463 [TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against aminoglycoside-induced nephrotoxicity. Kishore BK; Tulkens PM Arch Toxicol Suppl; 1989; 13():409-12. PubMed ID: 2476107 [No Abstract] [Full Text] [Related]
8. Reduction of gentamicin nephrotoxicity by the concomitant administration of poly-l-aspartic acid and poly-l-asparagine in rats. Beauchamp D; Laurent G; Maldague P; Tulkens PM Arch Toxicol Suppl; 1986; 9():306-9. PubMed ID: 3468909 [TBL] [Abstract][Full Text] [Related]
9. Effect of substrate organization on the activity and on the mechanism of gentamicin-induced inhibition of rat liver lysosomal phospholipase A1. Piret J; Kishore BK; Tulkens PM Biochem Pharmacol; 1992 Feb; 43(4):895-8. PubMed ID: 1540243 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of the thesaurismosis and altered lysosomal dynamics induced by poly-D-glutamic acid in kidney proximal tubular cells. Kishore BK; Fuming Lu; Maldague P; Tulkens PM; Courtoy PJ Lab Invest; 1996 Jun; 74(6):1025-37. PubMed ID: 8667607 [TBL] [Abstract][Full Text] [Related]
11. Leupeptin and E-64, inhibitors of cysteine proteinases, prevent gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Montenez JP; Kishore BK; Maldague P; Tulkens PM Toxicol Lett; 1994 Sep; 73(3):201-8. PubMed ID: 8091428 [TBL] [Abstract][Full Text] [Related]
12. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine. Kacew S Toxicol Appl Pharmacol; 1987 Dec; 91(3):469-76. PubMed ID: 3424375 [TBL] [Abstract][Full Text] [Related]
13. Poly-D-glutamic acid induces an acute lysosomal thesaurismosis of proximal tubules and a marked proliferation of interstitium in rat kidney. Kishore BK; Maldague P; Tulkens PM; Courtoy PJ Lab Invest; 1996 Jun; 74(6):1013-23. PubMed ID: 8667606 [TBL] [Abstract][Full Text] [Related]
14. Drug-phospholipid interactions: role in aminoglycoside nephrotoxicity. Kaloyanides GJ Ren Fail; 1992; 14(3):351-7. PubMed ID: 1509168 [TBL] [Abstract][Full Text] [Related]
15. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics--I. Biochemical analysis. Mingeot-Leclercq MP; Piret J; Brasseur R; Tulkens PM Biochem Pharmacol; 1990 Aug; 40(3):489-97. PubMed ID: 2383282 [TBL] [Abstract][Full Text] [Related]
17. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Giuliano RA; Paulus GJ; Verpooten GA; Pattyn VM; Pollet DE; Nouwen EJ; Laurent G; Carlier MB; Maldague P; Tulkens PM Kidney Int; 1984 Dec; 26(6):838-47. PubMed ID: 6533395 [TBL] [Abstract][Full Text] [Related]
18. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat. Ramsammy LS; Josepovitz C; Lane BP; Kaloyanides GJ J Pharmacol Exp Ther; 1989 Jul; 250(1):149-53. PubMed ID: 2746494 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of renal membrane binding and nephrotoxicity of gentamicin by polyasparagine and polyaspartic acid in the rat. Williams PD; Hottendorf GH Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):317-20. PubMed ID: 3838817 [TBL] [Abstract][Full Text] [Related]
20. Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. Van Bambeke F; Montenez JP; Piret J; Tulkens PM; Courtoy PJ; Mingeot-Leclercq MP Eur J Pharmacol; 1996 Oct; 314(1-2):203-14. PubMed ID: 8957238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]